Ozempic patent expiry has triggered a fresh pharma race in India. Sun Pharma, Cipla, and Dr Reddy’s are among 7 players ...

The high likelihood of utilizing another person or company’s patented technology led to an explosion of patent litigation ...

The United States ranks first in European patent applications, followed by Germany, while China rises to third place ahead of Japan and the Republic of ...

Wegovy HD’s approval came on the cusp of the drug’s patent expiry in India and China, which leaves it open to some biosimilar ...

Novartis AG faces major patent expiries but is buying pipeline assets to sustain growth. Click for this NVS update.

Germany continues to anchor Europe, holding strong as the number two player worldwide and the leader of the European ...

Large pharmaceutical companies, each with at least $20 billion in 2025 revenue, collectively reduced their workforces by more ...

Newron today announced its financial results and operational highlights for the business year ended Dec. 31, 2025, and ...

The majority of my work over the past 30 years has been in AI and machine learning. And I want to share some thoughts with ...

AIM ImmunoTech (AIM) stock jumped 97% after Japan's Patent Office approved its Ampligen cancer treatment patent covering ...

Equity-Insider.com News Commentary -- Big money is moving back into biotech. Institutional investors have been writing some of the largest checks in years, with major financing rounds already closing ...

This pair busts the myth of the sector being a desert for income investors.